Carlos Iván López Gil

Dr. Carlos Iván López Gil

Universidad Politécnica de Pachuca, Zempoala, Hidalgo, Mexico
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Yuridia Mercado FloresYuridia Mercado Flores
Yuridia Mercado Flores
ATAlejandro Tellez-Jurado
Alejandro Tellez-Jurado
CGCarlos Iván López Gil
Carlos Iván López Gil
MAMiguel Angel Anducho-Reyes
Miguel Angel Anducho-Reyes
Sposisorium reilianum is the causal agent of corn ear smut disease. Eleven genes have been identified in its genome that code for enzymes that could constitute its hemicellulosic system, three of which have been associated with two Endo-β-1,4-xylanases and one with α-L-arabinofuranosidase activity. In this study, the native protein extracellular with β-xylosidase activity, called SRBX1, produced by this basidiomycete was analyzed by performing production kinetics and its subsequent purification by gel filtration. The enzyme was characterized biochemically and sequenced. Finally, its synergism with Xylanase SRXL1 was determined. Its activity was higher in a medium with corn hemicellulose and glucose as carbon sources. The purified protein was a monomer associated with the sr16700 gene, with a molecular weight of 117 kDa and optimal activity at 60 °C in a pH range of 4–7, which had the ability to hydrolyze the ρ-nitrophenyl β-D-xylanopyranoside and ρ-Nitrophenyl α-L-arabinofuranoside substrates. Its activity was strongly inhibited by silver ions and presented Km and Vmax values of 2.5 mM and 0.2 μmol/min/mg, respectively, using ρ-nitrophenyl β-D-xylanopyranoside as a substrate. The enzyme degrades corn hemicellulose and birch xylan in combination and in sequential synergism with the xylanase SRXL1.

15 November 2024 in Molecules
Verified
Journal Article
Open access
PDF file
CGCarlos Iván López Gil
Carlos Iván López Gil
ATAlejandro Tellez-Jurado
Alejandro Tellez-Jurado
Marco Velasco-VelazquezMarco Velasco-Velazquez
Marco Velasco-Velazquez
MAMiguel Angel Anducho-Reyes
Miguel Angel Anducho-Reyes
The natural compounds PSK and PSP have antitumor and immunostimulant properties. These pharmacological benefits have been documented in vitro and in vivo, although there is no information in silico which describes the action mechanisms at the molecular level. In this study, the inverse docking method was used to identify the interactions of PSK and PSP with two local databases: BPAT with 66 antitumor proteins, and BPSIC with 138 surfaces and intracellular proteins. This led to the identification interactions and similarities of PSK and the AB680 inhibitor in the active site of CD73. It was also found that PSK binds to CD59, interacting with the amino acids APS22 and PHE23, which coincide with the rlLYd4 internalization inhibitor. With the isoform of the K-RAS protein, PSK bonded to the TYR32 amino acid at switch 1, while with BAK it bonded to the region of the α1 helix, while PSP bonded to the activation site and the C-terminal and N-terminal ends of that helix. In Bcl-2, PSK interacted at the binding site of the Venetoclax inhibitor, showing similarities with the amino acids ASP111, VAL133, LEU137, MET115, PHE112, and TYR108, while PSP had similarities with THR132, VAL133, LEU137, GLN118, MET115, APS111, PHE112, and PHE104.

30 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
CGCarlos Iván López Gil
Carlos Iván López Gil
ATAlejandro Tellez-Jurado
Alejandro Tellez-Jurado
Marco Velasco-VelazquezMarco Velasco-Velazquez
Marco Velasco-Velazquez
MAMiguel Angel Anducho-Reyes
Miguel Angel Anducho-Reyes
The natural compounds PSK and PSP have antitumor and immunostimulant properties. These pharmacological benefits have been documented in vitro and in vivo, although there is not information in silico which describes the action mechanisms at molecular level. In this study, the inverse docking method was used to identify the interactions of PSK and PSP with two local databases: BPAT with 66 antitumor proteins, and BPSIC with 138 surfaces and intracellular proteins. This led to the identification interactions and coincidences of PSK and AB680 inhibitor in the active site of CD73. It was also found that PSK bonds to CD59 interacting with amino acids APS22 and PHE23, which coincide with the rlLYd4 internalization inhibitor. With the isoform of K-RAS protein, PSK bonded to the TYR32 amino acid at switch 1, while with BAK it bonded to the region of the α1 helix, while PSP bonded to the activation site and the C-terminal and N-terminal ends of that helix. In Bcl-2, PSK interacted at the binding site of the Venetoclax inhibitor, showing coincidences with amino acids ASP111, VAL133, LEU137, MET115, PHE112, and TYR108; while PSP had coincidences with THR132, VAL133, LEU137, GLN118, MET115, APS111, PHE112, and PHE104.